S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

Sponsor
Southwest Oncology Group (Other)
Overall Status
Completed
CT.gov ID
NCT00016419
Collaborator
National Cancer Institute (NCI) (NIH)
130
94
65
1.4
0

Study Details

Study Description

Brief Summary

RATIONALE: Immunosuppressive therapy may improve bone marrow abnormalities and may be an effective treatment for myelodysplastic syndrome.

PURPOSE: Phase II trial to study the effectiveness of antithymocyte globulin plus cyclosporine in treating patients who have myelodysplastic syndrome.

Condition or Disease Intervention/Treatment Phase
Phase 2

Detailed Description

OBJECTIVES:
  • Determine the response in patients with myelodysplastic syndromes treated with anti-thymocyte globulin and cyclosporine.

  • Determine the frequency and severity of toxic effects of this regimen in these patients.

  • Assess the correlation between response to treatment and the in vitro assessment of T-lymphocyte subsets in these patients.

OUTLINE: This is a multicenter study. Patients are stratified according to myelodysplastic syndrome subclassification (refractory anemia [RA] vs RA with ringed sideroblasts vs RA with excess blasts).

Patients receive induction therapy comprising anti-thymocyte globulin IV over 6-12 hours on days 1-4 and oral cyclosporine twice daily on days 5-94 followed by a taper until day 124. Patients who relapse after a response of at least 60 days may receive reinduction therapy comprising oral cyclosporine twice daily on days 1-90 followed by a taper until day 120. Treatment continues in the absence of disease progression or unacceptable toxicity.

Patients are followed monthly for 6 months, every 2 months for 2 years, and then every 6 months for 3 years.

PROJECTED ACCRUAL: A total of 130 patients (53 with refractory anemia [RA], 33 with RA with ringed sideroblasts, and 44 with RA with excess blasts) will be accrued for this study within 14-22 months.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
130 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Phase II Study of Anti-Thymocyte Globulin and Cyclosporine for Patients With Myelodysplastic Syndrome (MDS)
Study Start Date :
Aug 1, 2001
Actual Primary Completion Date :
Jul 1, 2003
Actual Study Completion Date :
Jan 1, 2007

Outcome Measures

Primary Outcome Measures

  1. total response [after induction therapy is completed]

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Morphologically confirmed myelodysplastic syndromes (MDS)

  • Refractory anemia (RA)

  • RA with ringed sideroblasts

  • RA with excess blasts

  • Low, intermediate-1, or intermediate-2 risk by International Prognostic Scoring System criteria

  • MDS secondary to prior chemotherapy and/or radiotherapy for other malignant disorders allowed

  • Must have received prior transfusions of at least 4 units of red blood cells for anemia within the past 60 days

  • Must be concurrently registered on SWOG-S9910 and SWOG-9007

  • Ineligible for or refused participation in SWOG-S9920 (HLA-identical sibling peripheral blood stem cell transplantation)

PATIENT CHARACTERISTICS:
Age:
  • 15 and over
Performance status:
  • Zubrod 0-2
Life expectancy:
  • Not specified
Hematopoietic:
  • Not specified
Hepatic:
  • Not specified
Renal:
  • Not specified
Other:
  • No other malignancy within the past 2 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or adequately treated stage I or II cancer in complete remission

  • HIV negative

  • Not pregnant or nursing

  • Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:
Biologic therapy:
  • See Disease Characteristics

  • Prior cytokines (e.g., interferon or interleukin), colony-stimulating factors, or epoetin alfa allowed

  • No prior bone marrow or stem cell transplantation

  • No concurrent growth factors (including epoetin alfa) except filgrastim (G-CSF) or sargramostim (GM-CSF) for neutropenia

Chemotherapy:
  • See Disease Characteristics

  • No prior remission induction chemotherapy for MDS

  • Prior hydroxyurea allowed

Endocrine therapy:
  • Not specified
Radiotherapy:
  • See Disease Characteristics
Surgery:
  • Not specified
Other:
  • Prior amifostine allowed

  • No calcium-channel blockers (diltiazem, nicardipine, or verapamil), antifungals (fluconazole, itraconazole, or ketoconazole), antibiotics (clarithromycin or erythromycin), or other drugs (bromocriptine or danazol) that would increase cyclosporine concentrations for 48 hours before, during, and for 48 hours after cyclosporine

  • No antibiotics (nafcillin or rifampin) or anticonvulsants (carbamazepine, phenobarbital, or phenytoin) that would decrease cyclosporine concentrations for 14 days before and during cyclosporine

Contacts and Locations

Locations

Site City State Country Postal Code
1 MBCCOP - Gulf Coast Mobile Alabama United States 36688
2 CCOP - Greater Phoenix Phoenix Arizona United States 85006-2726
3 Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix Arizona United States 85012
4 Veterans Affairs Medical Center - Tucson Tucson Arizona United States 85723
5 Arizona Cancer Center Tucson Arizona United States 85724
6 University of Arkansas for Medical Sciences Little Rock Arkansas United States 72205
7 Veterans Affairs Medical Center - Little Rock (McClellan) Little Rock Arkansas United States 72205
8 City of Hope Comprehensive Cancer Center Duarte California United States 91010
9 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California United States 90033-0804
10 Veterans Affairs Medical Center - West Los Angeles Los Angeles California United States 90073
11 Jonsson Comprehensive Cancer Center, UCLA Los Angeles California United States 90095-1781
12 Veterans Affairs Outpatient Clinic - Martinez Martinez California United States 94553
13 CCOP - Bay Area Tumor Institute Oakland California United States 94609-3305
14 Chao Family Comprehensive Cancer Center Orange California United States 92868
15 University of California Davis Cancer Center Sacramento California United States 95817
16 CCOP - Santa Rosa Memorial Hospital Santa Rosa California United States 95403
17 David Grant Medical Center Travis Air Force Base California United States 94535
18 University of Colorado Cancer Center Denver Colorado United States 80010
19 Veterans Affairs Medical Center - Denver Denver Colorado United States 80220
20 MBCCOP - Howard University Cancer Center Washington District of Columbia United States 20060
21 CCOP - Atlanta Regional Atlanta Georgia United States 30342-1701
22 Dwight David Eisenhower Army Medical Center Fort Gordon Georgia United States 30905-5650
23 Cancer Research Center of Hawaii Honolulu Hawaii United States 96813-2424
24 Tripler Army Medical Center Honolulu Hawaii United States 96859-5000
25 MBCCOP - University of Illinois at Chicago Chicago Illinois United States 60612-7323
26 Veterans Affairs Medical Center - Chicago (Westside Hospital) Chicago Illinois United States 60612
27 CCOP - Central Illinois Decatur Illinois United States 62526
28 Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) Hines Illinois United States 60141
29 Loyola University Medical Center Maywood Illinois United States 60153-5500
30 Genesis Medical Center Davenport Iowa United States 52804
31 University of Kansas Medical Center Kansas City Kansas United States 66160-7353
32 CCOP - Wichita Wichita Kansas United States 67214-3882
33 Veterans Affairs Medical Center - Wichita Wichita Kansas United States 67218
34 Veterans Affairs Medical Center - Lexington Lexington Kentucky United States 40502-2236
35 Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky United States 40536-0084
36 MBCCOP - LSU Medical Center New Orleans Louisiana United States 70112
37 Tulane University School of Medicine New Orleans Louisiana United States 70112
38 Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana United States 71130-3932
39 Veterans Affairs Medical Center - Shreveport Shreveport Louisiana United States 71130
40 Boston Medical Center Boston Massachusetts United States 02118
41 Veterans Affairs Medical Center - Boston (Jamaica Plain) Jamaica Plain Massachusetts United States 02130
42 Veterans Affairs Medical Center - Ann Arbor Ann Arbor Michigan United States 48105
43 CCOP - Ann Arbor Regional Ann Arbor Michigan United States 48106
44 University of Michigan Comprehensive Cancer Center Ann Arbor Michigan United States 48109-0912
45 Barbara Ann Karmanos Cancer Institute Detroit Michigan United States 48201-1379
46 Veterans Affairs Medical Center - Detroit Detroit Michigan United States 48201-1932
47 Henry Ford Hospital Detroit Michigan United States 48202
48 CCOP - Grand Rapids Grand Rapids Michigan United States 49503
49 CCOP - Beaumont Royal Oak Michigan United States 48073-6769
50 Providence Hospital - Southfield Southfield Michigan United States 48075-9975
51 Veterans Affairs Medical Center - Biloxi Biloxi Mississippi United States 39531-2410
52 University of Mississippi Medical Center Jackson Mississippi United States 39216-4505
53 Veterans Affairs Medical Center - Jackson Jackson Mississippi United States 39216
54 Keesler Medical Center - Keesler AFB Keesler AFB Mississippi United States 39534-2576
55 Veterans Affairs Medical Center - Kansas City Kansas City Missouri United States 64128
56 CCOP - Kansas City Kansas City Missouri United States 64131
57 St. Louis University Health Sciences Center Saint Louis Missouri United States 63110
58 CCOP - St. Louis-Cape Girardeau Saint Louis Missouri United States 63141
59 CCOP - Cancer Research for the Ozarks Springfield Missouri United States 65807
60 CCOP - Montana Cancer Consortium Billings Montana United States 59101
61 Veterans Affairs Medical Center - Albuquerque Albuquerque New Mexico United States 87108-5138
62 MBCCOP - University of New Mexico HSC Albuquerque New Mexico United States 87131
63 Veterans Affairs Medical Center - Albany Albany New York United States 12208
64 Herbert Irving Comprehensive Cancer Center New York New York United States 10032
65 University of Rochester Medical Center Rochester New York United States 14642
66 CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina United States 27104-4241
67 Veterans Affairs Medical Center - Cincinnati Cincinnati Ohio United States 45220-2288
68 Barrett Cancer Center Cincinnati Ohio United States 45267-0501
69 Cleveland Clinic Taussig Cancer Center Cleveland Ohio United States 44195-9001
70 CCOP - Columbus Columbus Ohio United States 43206
71 Veterans Affairs Medical Center - Dayton Dayton Ohio United States 45428
72 CCOP - Dayton Dayton Ohio United States 45429
73 University of Oklahoma Health Sciences Center Oklahoma City Oklahoma United States 73104
74 Veterans Affairs Medical Center - Oklahoma City Oklahoma City Oklahoma United States 73104
75 Veterans Affairs Medical Center - Portland Portland Oregon United States 97207
76 CCOP - Columbia River Program Portland Oregon United States 97225
77 Oregon Cancer Institute Portland Oregon United States 97239
78 Veterans Affairs Medical Center - Charleston Charleston South Carolina United States 29401-5799
79 Medical University of South Carolina Charleston South Carolina United States 29425-0721
80 CCOP - Greenville Greenville South Carolina United States 29615
81 CCOP - Upstate Carolina Spartanburg South Carolina United States 29303
82 Brooke Army Medical Center Fort Sam Houston Texas United States 78234-6200
83 University of Texas Medical Branch Galveston Texas United States 77555-0565
84 Veterans Affairs Medical Center - Houston Houston Texas United States 77030
85 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78284-7845
86 Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio Texas United States 78284
87 Veterans Affairs Medical Center - Temple Temple Texas United States 76504
88 CCOP - Scott and White Hospital Temple Texas United States 76508
89 Huntsman Cancer Institute Salt Lake City Utah United States 84112-5550
90 Veterans Affairs Medical Center - Salt Lake City Salt Lake City Utah United States 84148
91 CCOP - Virginia Mason Research Center Seattle Washington United States 98101
92 Veterans Affairs Medical Center - Seattle Seattle Washington United States 98108
93 CCOP - Northwest Tacoma Washington United States 98405-0986
94 Madigan Army Medical Center Tacoma Washington United States 98431-5000

Sponsors and Collaborators

  • Southwest Oncology Group
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Charles A. Schiffer, MD, Barbara Ann Karmanos Cancer Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT00016419
Other Study ID Numbers:
  • S0020
  • S0020
  • U10CA032102
First Posted:
Jan 27, 2003
Last Update Posted:
Mar 6, 2015
Last Verified:
Mar 1, 2015

Study Results

No Results Posted as of Mar 6, 2015